Orasure Technologies Inc (OSUR): Total Liabilities
$62.34M
As of 2025-12-31
$42.77M
As of 2026-06-30
-7.9%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $62.34M | -10.1% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $69.32M | +32.9% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $52.17M | -34.6% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $79.75M | n/c | 2024-03-11, Balance as of period end |
| 2021-12-31 | $80.46M | +43.9% | 2023-03-03, Balance as of period end |
| 2020-12-31 | $55.90M | +32.6% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $42.15M | +30.9% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $32.19M | n/a | 2020-03-02, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $62.34M | -10.1% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $41.13M | -44.1% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $86.53M | -0.1% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $43.19M | -15.1% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $98.81M | +9.4% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $43.23M | -6.2% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $75.17M | -2.4% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $115.31M | +5.7% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $12.41M | +58.3% |
Compare OSUR, BBNX, NPCE, XTNT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗